#EASLCirrhosis
The session wraps up with Naim Alkhouri presenting results from the NAVIGATE trial of 2mg/kg, 4mg/kg belapectin or pbo in MASH cirrhosis with portal hypertension (n=~120 per arm) #EASLCirrhosis
May 10, 2025 at 12:25 PM